Aim: A prospective study was carried out to examine the efficacy of diode laser trabeculoplasty (DLT) in the treatment of pseudoexfoliative glaucoma (XFG). Material and Methods: Laser trabeculoplasty was performed by Zeiss VISULAS 532s diode pumped solid state laser on 69 eyes of 40 patients with XFG and primary open-angle glaucoma. Power of 600-1,200 mW was used, with a spot size of 100 microns and a pulse of 0.10 second. One hour before DLT brimonidine 0.1 % was administered and during seven days after the treatment Dexamethasone 1 % was administered. All patients underwent complete ophthalmic evaluation before and at intervals after treatment (seven days, one, three and six months and one year postoperatively). During the follow-up period, patients were treated with the same topical anti-glaucoma medicaments as before diode laser trabeculoplasty. Results: Before treatment in XFG patients mean intraocular pressure (IOP) was 23.7±2.6 mmHg and seven days after DLT it was 16.8 ± 2.1 mmHg that is 26.9 % decrease from the baseline, on day 30 it was 14.3 ± 2.2 mmHg which is 38.3 % decrease from the baseline, after 3 months 13.9 ± 2.4 mmHg (39.0 % decrease from the baseline), after six months 13.8 ± 2.7 mmHg or 39.9 % decrease from the baseline and after one year 15.1 ± 3.1 mmHg that makes 36.3 % decrease from the baseline. No side effects (either objective or subjective) were present in examined patients. Conclusions: There is statistically significant difference between IOP before and after diode laser trabeculoplasty, so it is concluded that diode laser trabeculoplasty is an effective mode of treatment for eyes with open-angle glaucoma especially in patients with XFG. Regarding ALT we can find three theories explaining the way it works. First of them is Wise and Witter and it is purely mechanical. 14 It says that, at the site of laser application, there is shrinkage of the meshwork which causes contraction of collagen in trabecular lamellae. It results in reduction of ring diameter and tightening of trabecular meshwork (TM)which together leads to opening of intratrabecular spaces between laser sites. 14-16 According to second theory there is trabecular cell replication and repopulation of the meshwork with fresh trabecular endothelial cells (these cells normally do not have a potential to divide). 15 It is presumed that these new cells have more normal physiological function. 17 The third theory uses the release of cytokines at the site of laser application in its explanation. This induces
bilateral disease. It can vary in time and onset and is characterised by abnormalities in the visual field that are caused by loss of optic nerve fibres. Open anterior chamber angle is characteristic in this disease.
Typical form of secondary open-angle glaucoma is pseudoexfoliative glaucoma (XFG). 1 Here, we can find deposits of whitish, fibril material in the anterior segment and chamber angle. It can be aggressive. We can usually find pseudoexfoliation material on the surface of lens, but also in the conjunctiva, wall of a short posterior ciliary artery, in eyelid skin, 2 as well as in other extraocular structures (extraocular rectus and oblique muscles, vortex veins and optic nerve sheaths).
When treating POAG our primary goal is to normalise intraocular pressure (IOP) and to maintain it this way. It can be achieved by using laser trabeculoplasty that is an effective painless method of lowering XFG. the aim of the study was to find the minimum time after Dlt that showed a decrease of iop and to establish the maximum iop decrease after which no further changes were expected. 
Material and Methods

Results
the results of this study were the following: two of 40 patients were excluded because they did not show up on scheduled control. other
During one year of follow-up period iop was significantly lower compared to baseline iop levels (p≤0.01). on day seven, month one, month three, month six and one year, statistically significant differences were found between the two groups (p=0.02), (p=0.058), (p=0.02), (p=0.002), (p=0.05) respectively. in both groups, at each visit in period from one month after Dlt to one year after Dlt, iop was significantly lower (p≤0.01) compared to baseline iop levels. there were no related adverse effects throughout the follow-up period in this study.
Conclusions
the efficacy and safety of Dlt was evaluated in patients with poaG and XFG in the prospective study. no iop decrease after Dlt until three months after procedure was seen in only three out of 69 eyes. By the end of follow-up period, the iop-lowering effect of Dlt was significant in both groups compared with baseline values. in poaG group it was 27.9 % (p<0.01) and in XFG group it was 36.3% (p<0.01). after 3 months the success of Dlt was 9.2 % greater in XFG group than in poaG group (p=0.002) which is in accordance with other studies. 
